Product logins

Find logins to all Clarivate products below.


Dialysis Access Treatment Devices | Market Insights | Japan | 2019

Dialysis access treatment trends differ significantly in Japan compared to those in other regions, with physicians choosing short AVF maturation times and strongly favoring hemodialysis over other treatments typically used for ESRD. However, the Japanese market continues to face a number of impediments, including biennial reimbursement cuts and more limited device availability.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for dialysis access treatment products in Japan across a 10-year period.

Related Medtech Insights Reports

Report
Large-Joint Reconstructive Implants – Market Insights – Japan
Growth in large-joint reconstructive procedure volumes is being driven by favorable demographic trends and increased demand for innovative technologies. However, market expansion is partly…
Report
Trauma Devices – Market Insights – Japan
The Japanese trauma device market will experience marginal growth through 2034, primarily fueled by the adoption of innovative, premium-priced technologies. This upward trend is further supported…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will experience moderate growth through 2034. This update reflects the impact of recent developments, including the launch of new-generation devices and…